Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003130427 | SCV003814345 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10 | 2021-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246052 | SCV004945790 | uncertain significance | Inborn genetic diseases | 2024-01-17 | criteria provided, single submitter | clinical testing | The c.992C>T (p.P331L) alteration is located in exon 6 (coding exon 6) of the TMEM5 gene. This alteration results from a C to T substitution at nucleotide position 992, causing the proline (P) at amino acid position 331 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |